Details for Patent: 9,168,238
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,168,238 protect, and when does it expire?
Patent 9,168,238 protects LEVOTHYROXINE SODIUM and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 9,168,238
Title: | Levothyroxine formulations |
Abstract: | A levothyroxine composition includes levothyroxine sodium and mannitol. The composition is a lyophilized solid. The composition may include from 100 to 500 micrograms levothyroxine sodium and from 2 to 4 milligrams mannitol. |
Inventor(s): | Jiang; John Zhiqiang (Skokie, IL), Usayapant; Arunya (Mundelein, IL), Monen; George (Woodridge, IL) |
Assignee: | Fresenius Kabi USA, LLC (Lake Zurich, IL) |
Application Number: | 14/641,426 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,168,238 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Use; |
Drugs Protected by US Patent 9,168,238
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231-001 | Jun 24, 2011 | AP | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231-002 | Jun 24, 2011 | AP | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231-003 | Jun 24, 2011 | AP | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,168,238
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2750664 | See Plans and Pricing | |||
World Intellectual Property Organization (WIPO) | 2013033194 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |